Quetiapine Extended Release (XR) for the Management of Psychotic Aggression or Agitation in Adult Acute Psychiatry

PHASE4UnknownINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions
SchizophreniaPsychosis
Interventions
DRUG

Quetiapine XR

The daily dose of oral Quetiapine XR at the start of therapy is 300 mg on Day 1, 600 mg on Day 2 and up to 800 mg after Day 2. The dose will be adjusted within the usual effective dose range of 400 to 800 mg/day, depending on the clinical response and tolerability of the individual patient.

Trial Locations (2)

3004

Alfred Psychiatry Research Centre, Melbourne

3065

St Vincent's Hospital, Melbourne, Fitzroy

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Bayside Health

OTHER_GOV